Population-Based Newborn Screening for Genetic Disorders When Multiple Mutation DNA Testing Is Incorporated: A Cystic Fibrosis Newborn Screening Model Demonstrating Increased Sensitivity but More Carrier Detections
Anne Marie Comeau(University of Massachusetts Chan Medical School), Roger B. Eaton(University of Massachusetts Chan Medical School), Henry L. Dorkin(Boston Children's Hospital), Brian O’Sullivan(University of Toronto), Richard B. Parad(Brigham and Women's Hospital), Robert Gerstle(Baystate Medical Center), Robert G. Zwerdling, Kenan Haver(Boston Children's Hospital), Mark Dovey(Boston Children's Hospital), David A. Waltz(Boston Children's Hospital), Allen Lapey(Boston Children's Hospital)
Cited by 154
Related Papers
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Prognostic Significance of p16 <sup>INK4A</sup> and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
|Journal of Clinical Oncology|2010|741
Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
|Journal of Clinical Oncology|2013|588